Advanced company searchLink opens in new window

EMENDA THERAPEUTICS LTD

Company number 11695185

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
21 Jul 2021 AA01 Previous accounting period extended from 30 November 2020 to 31 May 2021
18 Jul 2021 TM01 Termination of appointment of David Owen Bates as a director on 16 July 2021
18 Jul 2021 PSC07 Cessation of David Owen Bates as a person with significant control on 16 July 2021
21 Jan 2021 CS01 Confirmation statement made on 25 November 2020 with updates
19 Nov 2020 AA Total exemption full accounts made up to 30 November 2019
21 Oct 2020 SH01 Statement of capital following an allotment of shares on 21 October 2020
  • GBP 4.9142
16 Oct 2020 SH01 Statement of capital following an allotment of shares on 15 October 2020
  • GBP 4.6857
19 Jan 2020 AP01 Appointment of Mr Keith Joseph Macdonald as a director on 14 January 2020
09 Dec 2019 CH03 Secretary's details changed for Professor Steven James Harper on 25 March 2019
09 Dec 2019 CS01 Confirmation statement made on 25 November 2019 with updates
09 Dec 2019 PSC01 Notification of Jonathan Morris as a person with significant control on 24 November 2019
09 Dec 2019 PSC01 Notification of Steven James Harper as a person with significant control on 24 November 2019
09 Dec 2019 PSC01 Notification of Lucy Frances Donaldson as a person with significant control on 24 November 2019
09 Dec 2019 PSC01 Notification of David Owen Bates as a person with significant control on 24 November 2019
09 Dec 2019 PSC09 Withdrawal of a person with significant control statement on 9 December 2019
09 Dec 2019 CH01 Director's details changed for Professor Lucy Frances Donaldson on 27 February 2019
09 Dec 2019 CH01 Director's details changed for Professor Steven James Harper on 27 February 2019
09 Dec 2019 CH01 Director's details changed for Professor Jonathan Morris on 27 February 2019
09 Dec 2019 CH01 Director's details changed for Professor David Owen Bates on 27 February 2019
06 Nov 2019 SH02 Sub-division of shares on 4 September 2019
06 Nov 2019 RESOLUTIONS Resolutions
  • RES13 ‐ Sub division 04/09/2019
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES01 ‐ Resolution of adoption of Articles of Association
25 Oct 2019 SH01 Statement of capital following an allotment of shares on 4 September 2019
  • GBP 4.57
25 Oct 2019 AP01 Appointment of Dr Andrew Chapman as a director on 20 August 2019
27 Feb 2019 AD01 Registered office address changed from Shakespeare Martineau, Waterfront House Waterfront Plaza 35, Station Street Nottingham NG2 3DQ England to Shakespeare Martineau Waterfront House Waterfront Plaza 35 Station Street Nottingham Nottinghamshire NG2 3DQ on 27 February 2019
20 Feb 2019 AD01 Registered office address changed from C/O Veale Wasbrough Vizards Narrow Quay House, Narrow Quay Bristol BS1 4QA United Kingdom to Shakespeare Martineau, Waterfront House Waterfront Plaza 35, Station Street Nottingham NG2 3DQ on 20 February 2019